Katarzyna K. P.
- Country
- Poland
- Department
- Klinika Nefrologii Pediatrycznej
Research Overview
- Efficacy and Safety of Prolonged-Release Budesonide Versus Prednisone in Pediatric Primary IgA Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Pharmacokinetics, Safety, and Efficacy of Empagliflozin in Pediatric Patients with Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Pediatric Patients with Hyperkalemia: A Phase 2, Open-Label, Multiple Dose Study
Data & Insights
Has run more than one trial at 8 of 54 partner sites.
Specializations
Pediatric Nephrology
The investigator specializes in studying and treating primary IgA nephropathy in pediatric patients, with particular emphasis on developing innovative therapeutic approaches for managing kidney conditions in children.
- Pediatric kidney disorders
- IgA nephropathy treatment strategies
- Proteinuria management
Focused on evaluating therapeutic interventions for chronic kidney conditions affecting the pediatric population.
Therapeutic Innovation
Conducts research on novel treatment modalities for pediatric renal disorders, specifically investigating the potential of sustained-release formulations in nephrology treatment.
- Extended-release medications
- Corticosteroid therapy
- Combination treatment approaches
Explores advanced drug delivery systems to enhance therapeutic outcomes in pediatric nephrology.
Clinical Outcomes
Investigates the effectiveness of targeted therapeutic interventions in pediatric kidney disease, with specific focus on proteinuria reduction and long-term patient outcomes.
- Treatment efficacy assessment
- Safety monitoring
- Comparative therapeutic studies
Evaluates clinical responses to various treatment protocols in pediatric nephrology patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.